🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial evaluates the effects of CBM588 in combination with stan...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2021-11-01
Trial ID
NCT05122546
Treatments Being Tested
This research study, is studying the combination of cabozantinib and nivolu...
Status
Completed
Location
Boston Medical Center
Start Date
2019-12-26
Trial ID
NCT04197310
Treatments Being Tested
This research is being done to study the safety and feasibility of implanti...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-12-01
Trial ID
NCT05700461
Treatments Being Tested
The aim of the study is to evaluate the impact of digital monitoring of sel...
Status
Recruiting
Location
Centre Hospitalier d'Annecy
Start Date
2025-10-01
Trial ID
NCT07028125
Treatments Being Tested
The purpose of this study is in Part 1, to determine the safety of nivoluma...
Status
Completed
Location
Local Institution - 0005
Start Date
2020-09-11
Trial ID
NCT04540705
Treatments Being Tested
This is a multi-site, three-cohort phase II trial of cabozantinib for IMDC ...
Status
Recruiting
Location
Fox Chase Cancer Center
Start Date
2022-01-21
Trial ID
NCT05263050
Treatments Being Tested
This phase II trial compares the effect of immunotherapy with ipilimumab an...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2023-10-25
Trial ID
NCT05836571
The ARON-1 Study is designed as an International Multicentric Retrospective...
Status
Recruiting
Location
Ospedale di Macerata, UOC Oncologia
Start Date
2022-03-10
Trial ID
NCT05287464
Treatments Being Tested
This phase II trial compares cabozantinib alone and the combination of cabo...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham
Start Date
2020-07-13
Trial ID
NCT04310007
This is a multicenter, randomized, double-blinded, controlled Phase 3 trial...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #116
Start Date
2019-06-25
Trial ID
NCT03937219
Treatments Being Tested